PerkinElmer Company Profile (NYSE:PKI)

About PerkinElmer (NYSE:PKI)

PerkinElmer logoPerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. It provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. Its products include AAnalyst, Altus, Aquamatic, Avio, AxION, Clarus, DairyGuard, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, Cell carrier and cell::explorer. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. Its products include AutoDELFIA, BACS-on-Beads, Bioo Scientific, BoBs, Datalytix, Dexela, Dexela CMOS FPDs, Evolution, ViaCord, and Zephyr.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:PKI
  • CUSIP: 71404610
  • Web:
  • Market Cap: $6.91 billion
  • Outstanding Shares: 110,039,000
Average Prices:
  • 50 Day Moving Avg: $60.12
  • 200 Day Moving Avg: $55.34
  • 52 Week Range: $45.35 - $63.03
  • Trailing P/E Ratio: 30.62
  • Foreward P/E Ratio: 19.69
  • P/E Growth: 2.22
Sales & Book Value:
  • Annual Revenue: $2.13 billion
  • Price / Sales: 3.24
  • Book Value: $20.11 per share
  • Price / Book: 3.12
  • Annual Dividend: $0.28
  • Dividend Yield: 0.5%
  • EBIDTA: $409.68 million
  • Net Margins: 10.52%
  • Return on Equity: 14.26%
  • Return on Assets: 7.07%
  • Debt-to-Equity Ratio: 0.49%
  • Current Ratio: 1.97%
  • Quick Ratio: 1.56%
  • Average Volume: 625,071 shs.
  • Beta: 0.8
  • Short Ratio: 5.62

Frequently Asked Questions for PerkinElmer (NYSE:PKI)

What is PerkinElmer's stock symbol?

PerkinElmer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PKI."

How often does PerkinElmer pay dividends? What is the dividend yield for PerkinElmer?

PerkinElmer declared a quarterly dividend on Friday, April 28th. Investors of record on Friday, July 21st will be given a dividend of $0.07 per share on Thursday, August 10th. This represents a $0.28 annualized dividend and a yield of 0.45%. The ex-dividend date of this dividend is Wednesday, July 19th. View PerkinElmer's Dividend History.

How were PerkinElmer's earnings last quarter?

PerkinElmer, Inc. (NYSE:PKI) posted its quarterly earnings results on Thursday, May, 4th. The company reported $0.55 EPS for the quarter, beating the Zacks' consensus estimate of $0.54 by $0.01. The business had revenue of $514.12 million for the quarter, compared to analyst estimates of $506.81 million. PerkinElmer had a return on equity of 14.26% and a net margin of 10.52%. PerkinElmer's revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.50 EPS. View PerkinElmer's Earnings History.

What guidance has PerkinElmer issued on next quarter's earnings?

PerkinElmer updated its FY17 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.82.

Where is PerkinElmer's stock going? Where will PerkinElmer's stock price be in 2017?

11 brokerages have issued 1 year target prices for PerkinElmer's stock. Their forecasts range from $48.00 to $67.00. On average, they expect PerkinElmer's stock price to reach $56.78 in the next year. View Analyst Ratings for PerkinElmer.

What are analysts saying about PerkinElmer stock?

Here are some recent quotes from research analysts about PerkinElmer stock:

  • 1. Cantor Fitzgerald analysts commented, "Newborn screening in China continues to drive strong diagnostic growth, despite a slight decline in the Haoyuan nucleic acid testing. Diagnostic revenue in China was up more than 20% y/y in 1Q17. Despite a slight moderation in birth rates, uptake of the automated Genetic Screening Processor (GSP) has driven menu expansion. The company reports that 20-25% of the market is now screening for ~20 disorders, while the remaining 80% is screening for 2-4 disorders. India, the largest newborn screening opportunity with an estimated 26M annual births, continues to be relatively unpenetrated, but we do not anticipate a steep adoption ramp as the company experienced in China. Increase in reported revenue guidance leaves organic growth unchanged. The company raised its 2017 revenue guidance to $2.200-2.220B from $2.19-2.20B, implying 4-5% y/y reported revenue growth, compared with our prior estimate of $2.199B. Notably, the 4% organic revenue growth rate is unchanged, and the company expects a slightly lower FX headwind for 2017." (5/5/2017)
  • 2. According to Zacks Investment Research, "PerkinElmer reported a disappointing fourth quarter of 2016, missing the Zacks Consensus Estimate on both the counts. Over the past one year, the stock underperformed the broader industry trend in terms of price movement. The major concerns for PerkinElmer are a sluggish European macro-environment and restrained spending and challenges in Japan that are likely to hurt top-line growth in the near term. Organic revenues in the Discovery & Analytical Solutions (DAS) systems witnessed a decline in the last reported quarter on a year-over-year basis. Moreover, increasing exposure to the international markets enhances the risk of foreign exchange volatility impacting the company’s international sales. PerkinElmer continues to acquire a large number of companies. While this improves revenue opportunities, it adds to integration risks." (3/10/2017)

Who are some of PerkinElmer's key competitors?

Who owns PerkinElmer stock?

PerkinElmer's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.67%), Janus Capital Management LLC (5.98%), BlackRock Inc. (5.27%), State Street Corp (3.52%), Primecap Management Co. CA (3.22%) and Massachusetts Financial Services Co. MA (3.13%). Company insiders that own PerkinElmer stock include Alexis P Michas, Andrew Okun, Daniel R Tereau, Frank Anders Wilson, James Corbett, Joel S Goldberg, Kenton J Sicchitano, Patrick J Sullivan, Prahlad R Singh, Robert F Friel and Vicki L Sato. View Institutional Ownership Trends for PerkinElmer.

Who sold PerkinElmer stock? Who is selling PerkinElmer stock?

PerkinElmer's stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Janus Capital Management LLC, Impax Asset Management LTD, Shapiro Capital Management LLC, Edinburgh Partners Ltd, Credit Agricole S A, TIAA CREF Investment Management LLC and Candriam Luxembourg S.C.A.. Company insiders that have sold PerkinElmer stock in the last year include Alexis P Michas, Andrew Okun, Daniel R Tereau, Joel S Goldberg, Kenton J Sicchitano, Patrick J Sullivan, Prahlad R Singh, Robert F Friel and Vicki L Sato. View Insider Buying and Selling for PerkinElmer.

Who bought PerkinElmer stock? Who is buying PerkinElmer stock?

PerkinElmer's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Pictet Asset Management Ltd., Levin Capital Strategies L.P., Honeywell International Inc., Vanguard Group Inc., FIL Ltd, Quantitative Investment Management LLC and Scout Investments Inc.. View Insider Buying and Selling for PerkinElmer.

How do I buy PerkinElmer stock?

Shares of PerkinElmer can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of PerkinElmer stock cost?

One share of PerkinElmer stock can currently be purchased for approximately $62.80.

Analyst Ratings

Consensus Ratings for PerkinElmer (NYSE:PKI) (?)
Ratings Breakdown: 2 Sell Ratings, 6 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.09)
Consensus Price Target: $56.78 (9.59% downside)

Analysts' Ratings History for PerkinElmer (NYSE:PKI)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017Jefferies Group LLCReiterated RatingHold$49.00LowView Rating Details
5/15/2017Cantor FitzgeraldReiterated RatingHold$65.00LowView Rating Details
5/6/2017Barclays PLCSet Price TargetSell$55.00LowView Rating Details
4/7/2017Citigroup IncBoost Price TargetBuy$57.00 -> $67.00LowView Rating Details
3/27/2017Janney Montgomery ScottUpgradeNeutral -> BuyMediumView Rating Details
2/5/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
2/3/2017Bank of America CorpDowngradeNeutral -> Underperform$48.00N/AView Rating Details
1/18/2017Deutsche Bank AGReiterated RatingHold$55.00N/AView Rating Details
8/5/2016JPMorgan Chase & Co.Boost Price TargetNeutral$52.00 -> $55.00N/AView Rating Details
8/5/2016Morgan StanleySet Price TargetBuy$61.00N/AView Rating Details
8/5/2016MizuhoDowngradeBuy -> Neutral$56.00N/AView Rating Details
5/8/2016Robert W. BairdReiterated RatingBuyN/AView Rating Details
5/6/2016Stifel NicolausBoost Price TargetBuy$51.00 -> $59.00N/AView Rating Details
3/23/2016Goldman Sachs Group IncBoost Price Target$42.00N/AView Rating Details
1/7/2016Cowen and CompanyDowngradeOutperform -> Market Perform$55.00N/AView Rating Details
12/3/2015WedbushDowngradeOutperform -> Neutral$56.00N/AView Rating Details
11/6/2015Evercore ISIBoost Price TargetHold$51.00 -> $53.00N/AView Rating Details
8/27/2015Maxim GroupReiterated RatingBuy$62.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for PerkinElmer (NYSE:PKI)
Earnings by Quarter for PerkinElmer (NYSE:PKI)
Earnings History by Quarter for PerkinElmer (NYSE:PKI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q1 2017$0.54$0.55$506.81 million$514.12 millionViewListenView Earnings Details
11/7/2016Q3$0.66$0.68$572.03 million$548.00 millionViewListenView Earnings Details
5/5/2016Q116$0.51$0.56$532.55 million$538.70 millionViewN/AView Earnings Details
11/5/2015Q315$0.60$0.60$554.88 million$563.00 millionViewN/AView Earnings Details
7/30/2015Q2$0.59$0.60$555.66 million$564.00 millionViewListenView Earnings Details
4/30/2015Q115$0.46$0.50$537.27 million$526.90 millionViewN/AView Earnings Details
1/29/2015Q414$0.78$0.85$602.35 million$608.60 millionViewN/AView Earnings Details
10/30/2014Q3$0.57$0.67$550.40 million$542.05 millionViewListenView Earnings Details
8/7/2014Q2$0.59$0.59$572.26 million$556.20 millionViewListenView Earnings Details
4/24/2014Q114$0.44$0.46$531.31 million$531.90 millionViewListenView Earnings Details
1/30/2014Q413$0.70$0.73$588.95 million$594.00 millionViewListenView Earnings Details
10/30/2013Q313$0.48$0.49$523.84 million$524.30 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.48$0.51$532.95 million$543.30 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.48$0.36$532.25 million$505.38 millionViewListenView Earnings Details
1/31/2013Q4 2012$0.65$0.65$577.94 million$577.00 millionViewListenView Earnings Details
10/25/2012$0.44$0.45ViewN/AView Earnings Details
8/2/2012$0.47$0.53ViewN/AView Earnings Details
4/26/2012$0.41$0.43ViewN/AView Earnings Details
2/2/2012$0.51$0.62ViewN/AView Earnings Details
11/3/2011$0.39$0.41ViewN/AView Earnings Details
8/4/2011$0.40$0.42ViewN/AView Earnings Details
5/5/2011$0.31$0.34ViewN/AView Earnings Details
2/3/2011$0.41$0.44ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for PerkinElmer (NYSE:PKI)
2017 EPS Consensus Estimate: $2.91
2018 EPS Consensus Estimate: $3.21
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.60$0.60$0.60
Q2 20171$0.67$0.67$0.67
Q3 20171$0.73$0.73$0.73
Q4 20171$0.91$0.91$0.91
Q1 20181$0.74$0.74$0.74
Q2 20181$0.80$0.80$0.80
Q3 20181$0.79$0.79$0.79
Q4 20181$0.88$0.88$0.88
(Data provided by Zacks Investment Research)


Current Dividend Information for PerkinElmer (NYSE:PKI)
Next Dividend:8/10/2017
Annual Dividend:$0.28
Dividend Yield:0.45%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:13.15% (Trailing 12 Months of Earnings)
9.79% (Based on This Year's Estimates)
8.78% (Based on Next Year's Estimates)
Dividend Payments by Quarter for PerkinElmer (NYSE:PKI)

Dividend History by Quarter for PerkinElmer (NYSE:PKI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for PerkinElmer (NYSE:PKI)
Insider Ownership Percentage: 2.30%
Institutional Ownership Percentage: 89.82%
Insider Trades by Quarter for PerkinElmer (NYSE:PKI)
Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)
Insider Trades by Quarter for PerkinElmer (NYSE:PKI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Patrick J SullivanDirectorSell6,628$62.59$414,846.52View SEC Filing  
5/4/2017Robert F FrielInsiderSell25,100$60.00$1,506,000.00View SEC Filing  
4/27/2017Robert F FrielInsiderSell124,837$60.11$7,503,952.07View SEC Filing  
3/20/2017Andrew OkunInsiderSell3,000$57.27$171,810.00View SEC Filing  
3/13/2017Joel S GoldbergInsiderSell30,710$55.45$1,702,869.50View SEC Filing  
2/21/2017Alexis P. MichasDirectorSell8,308$55.60$461,924.80View SEC Filing  
2/15/2017Prahlad R SinghInsiderSell9,576$55.00$526,680.00View SEC Filing  
2/9/2017Daniel R TereauInsiderSell5,001$53.16$265,853.16View SEC Filing  
2/9/2017Vicki L SatoDirectorSell8,308$54.01$448,715.08View SEC Filing  
2/6/2017Daniel R TereauInsiderSell4,069$52.01$211,628.69View SEC Filing  
12/1/2016Alexis P. MichasDirectorSell15,000$51.00$765,000.00View SEC Filing  
9/22/2016Joel S GoldbergInsiderSell38,095$55.00$2,095,225.00View SEC Filing  
9/12/2016Daniel R TereauInsiderSell18,866$52.00$981,032.00View SEC Filing  
8/24/2016Kenton J SicchitanoDirectorSell15,189$54.87$833,420.43View SEC Filing  
8/17/2016Patrick J SullivanDirectorSell8,308$54.74$454,779.92View SEC Filing  
6/2/2016Alexis P MichasDirectorSell1,953$54.85$107,122.05View SEC Filing  
5/24/2016Robert F FrielCEOSell128,300$55.01$7,057,783.00View SEC Filing  
5/16/2016Robert F FrielCEOSell109,000$55.01$5,996,090.00View SEC Filing  
5/11/2016Robert F FrielCEOSell10,685$55.01$587,781.85View SEC Filing  
5/10/2016Vicki L SatoDirectorSell12,586$54.51$686,062.86View SEC Filing  
5/6/2016Robert F FrielCEOSell4,116$55.00$226,380.00View SEC Filing  
4/18/2016Daniel R TereauInsiderSell2,158$50.79$109,604.82View SEC Filing  
3/21/2016James CorbettInsiderSell1,723$48.74$83,979.02View SEC Filing  
2/24/2016Alexis P. MichasDirectorSell10,000$47.56$475,600.00View SEC Filing  
12/3/2015Kenton J SicchitanoDirectorSell10,216$51.05$521,526.80View SEC Filing  
11/3/2015Frank Anders WilsoninsiderSell16,380$52.69$863,062.20View SEC Filing  
10/23/2015Andrew OkunInsiderSell2,000$50.00$100,000.00View SEC Filing  
9/14/2015James CorbettInsiderSell3,000$47.59$142,770.00View SEC Filing  
9/3/2015Kenton J. SicchitanoDirectorSell12,586$47.88$602,617.68View SEC Filing  
6/5/2015Alexis P MichasDirectorSell20,000$52.25$1,045,000.00View SEC Filing  
6/3/2015Frank Anders WilsonInsiderSell16,380$52.60$861,588.00View SEC Filing  
3/27/2015Joel S GoldbergInsiderSell10,646$51.00$542,946.00View SEC Filing  
3/23/2015Andrew OkunInsiderSell2,000$50.09$100,180.00View SEC Filing  
3/20/2015James CorbettInsiderSell5,157$50.23$259,036.11View SEC Filing  
3/18/2015Joel S GoldbergInsiderSell9,000$49.00$441,000.00View SEC Filing  
3/6/2015Patrick J SullivanDirectorSell12,586$46.90$590,283.40View SEC Filing  
3/5/2015Alexis P MichasDirectorSell8,892$47.00$417,924.00View SEC Filing  
3/5/2015Joel S GoldbergInsiderSell9,000$47.00$423,000.00View SEC Filing  
2/10/2015Vicki L SatoDirectorSell24,000$45.55$1,093,200.00View SEC Filing  
2/9/2015Andrew OkunInsiderSell6,262$45.82$286,924.84View SEC Filing  
2/3/2015Nicholas A LopardoDirectorSell8,892$46.30$411,699.60View SEC Filing  
2/3/2015Robert F FrielCEOSell60,709$46.26$2,808,398.34View SEC Filing  
2/2/2015Robert F FrielCEOSell319,065$46.02$14,683,371.30View SEC Filing  
11/14/2014James C MullenDirectorSell8,892$43.73$388,847.16View SEC Filing  
11/13/2014Patrick J SullivanDirectorSell8,892$43.46$386,446.32View SEC Filing  
9/4/2014Kenton J SicchitanoDirectorSell8,892$44.98$399,962.16View SEC Filing  
7/2/2014Daniel R MarshakSVPSell12,000$48.00$576,000.00View SEC Filing  
6/26/2014Daniel R MarshakSVPSell10,000$46.60$466,000.00View SEC Filing  
6/19/2014James CorbettInsiderSell57,126$46.69$2,667,212.94View SEC Filing  
6/9/2014Maurice H TenneyInsiderSell5,504$47.26$260,119.04View SEC Filing  
6/9/2014Robert F FrielCEOSell124,858$46.70$5,830,868.60View SEC Filing  
6/5/2014Alexis P MichasDirectorSell9,146$46.30$423,459.80View SEC Filing  
6/2/2014Alexis P MichasDirectorSell5,854$45.00$263,430.00View SEC Filing  
6/2/2014Joel S GoldbergInsiderSell17,000$45.11$766,870.00View SEC Filing  
5/12/2014Alexis MichasDirectorSell5,000$44.40$222,000.00View SEC Filing  
4/29/2014Nicholas LopardoDirectorSell12,951$41.98$543,682.98View SEC Filing  
4/7/2014James CorbettInsiderSell22,027$45.11$993,637.97View SEC Filing  
3/12/2014Daniel MarshakSVPSell19,292$45.29$873,734.68View SEC Filing  
3/11/2014John LetcherSVPSell41,000$45.40$1,861,400.00View SEC Filing  
3/7/2014Andrew OkunCAOSell9,398$46.35$435,597.30View SEC Filing  
2/27/2014Alexis MichasDirectorSell5,000$45.25$226,250.00View SEC Filing  
2/14/2014Vicki SatoDirectorSell21,843$43.97$960,436.71View SEC Filing  
2/7/2014James MullenDirectorSell12,951$43.73$566,347.23View SEC Filing  
12/13/2013Maurice TenneyInsiderSell25,000$38.91$972,750.00View SEC Filing  
12/10/2013Daniel MarshakSVPSell12,183$39.59$482,324.97View SEC Filing  
11/14/2013Robert FrielCEOSell112,461$37.14$4,176,801.54View SEC Filing  
9/10/2013Robert F FrielCEOSell141,000$37.45$5,280,450.00View SEC Filing  
9/6/2013Andrew OkunCAOSell6,805$36.86$250,832.30View SEC Filing  
5/1/2013Alexis P MichasDirectorSell6,440$30.85$198,674.00View SEC Filing  
4/30/2013James C MullenDirectorSell6,440$30.31$195,196.40View SEC Filing  
4/11/2013Maurice H TenneyInsiderSell9,500$35.00$332,500.00View SEC Filing  
9/13/2012Robert F FrielCEOSell50,565$29.00$1,466,385.00View SEC Filing  
8/9/2012Kenton J SicchitanoDirectorSell9,454$27.93$264,050.22View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for PerkinElmer (NYSE:PKI)
Latest Headlines for PerkinElmer (NYSE:PKI)
DateHeadline logoJuly 21st Options Now Available For PerkinElmer (PKI) - May 23 at 9:53 AM logoInsider Selling: PerkinElmer, Inc. (PKI) Director Sells 6,628 Shares of Stock - May 16 at 7:32 PM logoJefferies Group Comments on PerkinElmer, Inc.'s Q2 2017 Earnings (PKI) - May 11 at 7:54 AM logoPerkinElmer, Inc. (PKI) to Post FY2017 Earnings of $2.90 Per Share, Cantor Fitzgerald Forecasts - May 10 at 9:59 AM logoQ3 2017 EPS Estimates for PerkinElmer, Inc. Lifted by Analyst (PKI) - May 10 at 9:06 AM logoPerkinElmer, Inc. (PKI) Receives Average Rating of "Hold" from Brokerages - May 9 at 10:52 AM logoJefferies Group LLC Reiterates Hold Rating for PerkinElmer, Inc. (PKI) - May 7 at 10:32 AM logoPerkinElmer, Inc. (PKI) Expected to Post Quarterly Sales of $550.13 Million - May 7 at 7:52 AM logoPerkinElmer, Inc. (PKI) Given "Hold" Rating at Cantor Fitzgerald - May 6 at 2:04 PM logoPerkinElmer, Inc. (PKI) Announces Earnings Results - May 5 at 11:31 PM logoPerkinElmer, Inc. (PKI) Insider Robert F. Friel Sells 25,100 Shares - May 5 at 10:57 PM logoZacks: Analysts Expect PerkinElmer, Inc. (PKI) to Announce $0.67 Earnings Per Share - May 5 at 8:22 PM logoPerkinElmer raises full-year profit view after first-quarter results - May 5 at 7:29 PM logoEdited Transcript of PKI earnings conference call or presentation 4-May-17 9:00pm GMT - May 5 at 8:41 AM logoPerkinElmer, Inc. (PKI) Releases FY17 Earnings Guidance - May 4 at 7:34 PM logoPerkinElmer Announces Financial Results for the First Quarter of 2017 - May 4 at 7:24 PM logoPerkinElmer profit, revenue edge past Wall Street forecasts - May 4 at 7:24 PM logoPerkinElmer beats Street 1Q forecasts - May 4 at 7:24 PM logoUPDATE 1-PerkinElmer raises full-year profit view after first-quarter results - May 4 at 7:24 PM logoCan PerkinElmer (PKI) Deliver a Beat this Earnings Season? - May 2 at 10:23 AM logoPerkinElmer Completes Sale of Medical Imaging Business to Varex Imaging - May 1 at 6:22 PM logoPerkinElmer Takes Cautious Approach to M&A - April 30 at 8:32 PM logoPerkinElmer (PKI) Receives Daily Media Impact Rating of 0.15 - April 30 at 12:45 AM logoPerkinElmer, Inc. (PKI) Insider Robert F. Friel Sells 124,837 Shares - April 29 at 12:38 AM logoPerkinElmer, Inc. (PKI) to Issue Quarterly Dividend of $0.07 - April 29 at 12:30 AM logoSomewhat Favorable News Coverage Somewhat Likely to Affect PerkinElmer (PKI) Stock Price - April 25 at 7:49 PM logoPerkinElmer, Inc. (PKI) Downgraded to Neutral at Cantor Fitzgerald - April 23 at 11:01 AM logoSomewhat Favorable News Coverage Likely to Affect PerkinElmer (PKI) Stock Price - April 22 at 1:14 PM logoWhy One Analyst Is Growing Very Bullish on Life Sciences - April 19 at 9:53 AM logoPerkinElmer Reaches Analyst Target Price - April 18 at 6:33 PM logoPerkinElmer (PKI) Given Daily Coverage Optimism Score of 0.15 - April 18 at 2:54 PM logoSomewhat Positive Press Coverage Very Likely to Effect PerkinElmer (PKI) Stock Price - April 15 at 1:21 PM logoZacks: Brokerages Anticipate PerkinElmer, Inc. (PKI) to Post $0.54 Earnings Per Share - April 14 at 8:23 PM logoPerkinElmer, Inc. (PKI) Receives Consensus Recommendation of "Hold" from Analysts - April 14 at 12:08 PM logoPerkinElmer, Inc. (PKI) Stock Rating Reaffirmed by Citigroup Inc - April 7 at 7:52 PM logoPerkinElmer to Hold Earnings Call on Thursday, May 4, 2017 - April 7 at 7:37 PM logoEx-Dividend Reminder: PerkinElmer, Pennymac Mortgage Investment Trust and Mid-America Apartment Communities - April 7 at 11:55 AM logoPhase I Clinical Trial Examines Safety of Using Cord Blood Stem Cells for Treating Children with Autism Spectrum Disorder - April 7 at 11:55 AM logoPerkinElmer, Inc. (PKI) Raised to Buy at Janney Montgomery Scott - March 27 at 5:45 PM logoMedTech Long-Term Prospects Impress: Which Stocks to Buy? - March 22 at 7:13 PM logoAndrew Okun Sells 3,000 Shares of PerkinElmer, Inc. (PKI) Stock - March 21 at 7:40 PM logoPerkinElmer, Inc. (PKI) Given Consensus Rating of "Hold" by Brokerages - March 20 at 1:40 PM logoPerkinElmer (PKI) Up 2% Since Earnings Report: Can It Continue? - March 8 at 9:00 AM logoPERKINELMER INC Financials - March 4 at 7:16 PM logoPERKINELMER INC Files SEC form 10-K, Annual Report - February 28 at 7:50 PM logoPerkinelmer to Present at Barclays Capital Global Healthcare Conference - February 16 at 6:51 PM logoPerkinelmer to Present at Barclays Capital Global Healthcare Conference - February 16 at 6:51 PM logoBullish Two Hundred Day Moving Average Cross - PKI - February 8 at 8:11 PM logoEdited Transcript of PKI earnings conference call or presentation 2-Feb-17 10:00pm GMT - February 4 at 1:03 AM logoPerkinElmer downgraded by BofA/Merrill - February 4 at 1:03 AM



PerkinElmer (PKI) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff